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Plasmapheresis Combined with Leukocytapheresis for Patients with 
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Aihara, Shumpei Yokota 
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BACKGROUND: Early treatment with intravenous immunoglobulin (IVIO) reduces 
the risk for coronary artery lesions of Kawasaki disease (KD).(CAL). However, a study 
found that 15.8% of KD patients were IVIG-refractory and of them 38.5% developed 
CAL (2). We previously reported the efficacy of plasmapheresis(PE) to prevent CALs in 
IVIG-refractory KD (E J Pediatr 163:263-4,2004). By now over 50 patients have heen 
treated with PE in our institute. PE significantly reduced the incidence of CALs about 
15% of them. Autoimmunity is related to the pathogenesis of KD. Especially, activated 
neutrophils migrate, attach to the vascular wall and infiltrate it. Leukocytapheresis 
(LeAP) may prove effective in KD, but there has been no report up to now. 
OBJECTIVE: To investigate the efficacy of PE/LCAP combination therapy for fVIG-
refractory KD, and compare it with PE therapy alone. 
DESIGNIMETHODS: After obtaining the parents' informed consent and the approval 
from the ethical committee of our hospital , PE/LCAP was performed in II children ( 
6 males, 5 fema les, 10months old - 5 years 8 months old) with fVIG-refractory KD. 
For PE, 1-1.5 plasma volume was replaced with 5% albumin per day; for LCAP, 
leukocytes were removed from 1- 1.5 blood volume per day. PE/LCAP was continued 
until the resolution of fever. 
RESULTS : Nine patients successfully recovered without CAL. One patient showed 
transient mild dilatation. One patient had moderate dil atation and needed warfarin 
therapy, but th is patient had already presented moderate dilatation at the time of the 
initiation of PE/LCAP. The average duration of the therapy was 2.7 ± 1.1 days, which 
was about one day shorter than PE therapy alone (3.6 ± 1.1 days). There was no severe 
adverse events. 
CONCLUSIONS: LCAP/PE therapy prevented the development of CAL in these 
patients. Although the number of patients was small, PE/LCAP was as effective 
as PE, and shortened the duration of blood purification therapy. At the same time, 
we establ ished the method for LCAP using the leukocyte removal filter for blood 
transfusion even in small infants ( lowest weight was 7 kg) . Further studies involving 
a larger number of cases wi ll be needed to elucidate the mechanism for the efficacy of 
LCAP in KD patients. 
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Patient with Menkes Disease 
Hiroko Kodama, Chie Fujisawa, Yan Hong Gu, Chie Fujisawa, Kastuaki Shiga, 
Kastuaki Shiga, Kastuaki Shiga, Fumiaya Kaga, Fumiaya Kaga, Fumjaya Kaga 
Department of Pediatrics. Teikyo UniverSity School of Medicine. To~yo. Japan. 
BACKGROUND: Menkes disease is an X-linked recessive disorder of copper 
metabolism characterized by progressive neurological degeneration and connective 
tissue abnormalities. The disease is caused by mutations in the ATP7A gene, which 
encodes a copper- transporting P-type ATPase. ATP7A gene consists of 23 exons 
spanning a genomic region of about 150 kbp.Mutations in the ATP7A gene have been 
reported to show variety in patients with Menkes disease. Only few female patients with 
Menkes disease and chromosomal abnormalities have been reported. 
OBJECTIVE: We examined the mutations in the ATP7A gene in 43 unrelated male 
patients and a female patient. The female patient had a nomlal chromosome karyotype 
of46 XX. 
DESIGNIMETHODS: Genomic DNA was prepared from peripheral blood lymphocytes, 
cultured fibroblasts or amniocytes, and amplified by PCR. The direct sequencing of 
exons was performed with a DNA analyzer. RT-PCR was also examined from the 
samples 
RESULTS: Forty different mutations were identified in the 43 male patients; 10 
nonsense mutations, 6 missense mutation, 10 splice-site mutations, and 14 insertion! 
deletion mutations. No mutation was found in the female patient. Mutation was not 
found in the genes of HAH I, a chaperon protein of copper, and CTR I, a transporter 
of copper on the plasma membrane, in the female patient. RT-PCR of ATP7A cDNA 
revealed that ATP7A of the female patients is normal. 
CONCLUSIONS: These results indicate that mutations vary from a patient to a 
patient with Menkes disease. These results suggest that there is an unknown regulation 
mechanism of copper which is disturbed in the female patient. 
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Differences in the Plasma Proteome of Patients with Kawasaki 
Disease 
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BACKGROUND: Kawasaki di sease (KD) is an acute multi-systemi c vasculitis 
syndrome of unknown etiology occurring mostly in chi ldren <5 yr of age. It is also the 
leading cause of acquired heart disease during childhood in the developing countries. 
OBJECTIVE: In this study, our goal was to elucidate potential differences in plasma 
between KD and control groups. 
DESIGNIMETHODS : Plasma samples of 10 KD and 10 fever control groups were 
enrolled in this study and compared with proteomics technology. Using proteome 
analysis, two-dimensional gel electrophoresis detected more than 200 spots per gel. 
RESULTS: A differential protein expression was discovered between KD and fever 
control groups. Fibrinogen beta and gamma chains, alpha-I-antitrypsin were increased 
in KD plasma, whereas CD5 antigen-like precursor (CD5L), immunoglobulin lambda 
chain, clusterin were decreased. 
CONCLUSIONS: Our results show that proteomic profiling is a useful approach for 
detecting protein expression in Kawasaki disease. Further studies are needed to explore 
the roles of these candidate proteins. 
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BACKGROUND: Data on birth defects from population-based studies originating from 
developing countries such as Malaysia are lacking. 
OBJECTIVE: The objectives of this study are to determine the epidemiology of birth 
defects and to identify risk factors for major birth defects in Malaysian births. 
DESIGNIMETHODS: This is a descriptive study of all Malaysian births with major 
birth defects identified over a l4-month period using a case-controlled population-based 
birth defect register. All major birth defects in infants 500 g (or more or 22 weeks) till 
one week of life, in Kinta district, state of Perak, Malaysia are enrolled. Ethical approval 
and parental consents were obtained. The mothers of the cases were interviewed. All 
the affected babies were examined by attending doctors and clinical photographs were 
taken, after informed consent was obtained. Blood samples were sent for chromosomal 
studies. The abnormalities were classified by an organ system classification according to 
ICD I O. Two normal controls for each case from same institution of birth, matched for 
sex and ethnic group were chosen. 
RESULTS: There were 253 babies with major birth defects in 17720 births, giving birth 
prevalence of I in 70 (1.43%) (95% CI: 0.87-1.99). The exact syndromic diagnosis 
of the babies with multiple birth defects could be identified in 62/82 (77.5%) babies. 
Isolated major birth defects were cardiovascular (\3.8%), cleft lip and palate (11.9%), 
clubfeet (9. 1%) and central nervous system abnormalities (7.9%). The babies with major 
birth defects were lighter, more premature, had higher Caesarean section rates, required 
prolonged hospitalization and more specialist care and had a perinatal mortality rate of 
25.2%. Mothers with affected babies were older, had birth defects themselves or in their 
relatives, had a consanguinity rate of 2.4%, and had higher rates of previous abortions. 
Risk factors identified for birth defects using multivariate logistic regression were 
maternal insulin-dependent diabetes, previous abortions, maternal recall of exposure to 
teratogens during pregnancy but not lack of periconceptional folate supplementation. 
CONCLUSIONS: Pre-natal screening for insulin dependent diabetes, counselling 
and investigating causes for previous abortions and public education on avoidance of 
temtogens may reduce birth defects in this population. A Birth Defect Register must he 
set up to monitor these developments in Malaysia. 
